Molecular weight approximately 5136 Da
Consistent and significant real-world research is critical as GLP-1 drugs are a considerable driver of cost and utilization for our clients and employer groups. This data contributes to Primes holistic management approach to GLP-1 therapy, which was first showcased with its award-winning Year-1 persistence and cost-of-care data in 2023, Year-2 persistence data in July 2024 and Year-2 cost-of-care data in October 2024
Concurrently, IGF-1 also experienced an increase, approximately 28%, indicating an enhancement in the growth hormone-IGF-1 axis functionality
Our philosophy is built around delivering A medically supervised, affordable, results-driven weight loss program delivered 100% virtually
Pharmaceutical and/ or dietetic compositions, containing as their active ingredient the combination according to claims 1-3, and at least one pharmaceutically acceptable excipient
For detailed guidance on injection technique, our complete peptide injection guide covers everything from drawing the correct dose to proper site preparation